Canada Pension Plan Investment Board
ANIK icon

Canada Pension Plan Investment Board’s Anika Therapeutics ANIK Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$319K Hold
22,000
– – ﹤0.01% 1401
2025
Q4 		$211K Buy
+22,000
New +$211K ﹤0.01% 1642

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Canada Pension Plan Investment Board's ANIK Position: Q1 2026 in Review

Canada Pension Plan Investment Board held its Anika Therapeutics (ANIK) position steady in Q1 2026 at 22,000 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

Canada Pension Plan Investment Board first reported a position in ANIK in Q4 2025 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Canada Pension Plan Investment Board held 22,000 shares of Anika Therapeutics worth $319K as of Q1 2026.
  • Canada Pension Plan Investment Board left its Anika Therapeutics share count unchanged in Q1 2026.
  • Anika Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1401 holding.
  • Canada Pension Plan Investment Board first reported a position in Anika Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.